What's breaking now, across thousands of outlets.
Dr Reddy’s Laboratories reported a 36% year-on-year profit decline to Rs 913.4 crore in Q2 FY27, while revenue slipped 1.5%. North America weakness pressured performance, offset partly by growth in India and emerging markets, alongside biosimilar approvals and strategic partnerships.
We haven't written up this one. The Economic Times - Top News has the full story — the link below goes straight to it.
(RTTNews) - Oregon Bancorp, Inc. (ORBN) released earnings for third quarter that Dropped, from the same period last year
Key PointsStrive stock jumped 20.5% this week after closing a $630 million preferred stock offering to fund additional Bitcoin purchases.
The rocket company is looking pretty unstoppable right now.
Monetising America has pleased tycoons but not citizens
Bombardier plans to invest $270 million to expand its American infrastructure footprint and hire 800 U.S. workers, days after President Trump seemed to soften his rhetoric against the Montreal…
